CliffBio
small molecule

XENON XE 133

XENON XE-133

Loss of exclusivity—loss of exclusivity
CompanyLantheus Medical Imaging →See this company's full patent-cliff portfolio

Drug detail

Brand nameXENON XE 133
Active ingredientXENON XE-133
Strength6.3mCi/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
Marketing statusDISCN

More from Lantheus Medical Imaging

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

XENON XE 133 patent cliff — loss of exclusivity — | CliffBio